These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32521182)

  • 1. Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review.
    Najafi M; Tavakol S; Zarrabi A; Ashrafizadeh M
    Arch Physiol Biochem; 2022 Dec; 128(6):1438-1452. PubMed ID: 32521182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity.
    Sanchez-Gonzalez PD; Lopez-Hernandez FJ; Perez-Barriocanal F; Morales AI; Lopez-Novoa JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3484-95. PubMed ID: 21602180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity.
    Rezaee R; Momtazi AA; Monemi A; Sahebkar A
    Pharmacol Res; 2017 Mar; 117():218-227. PubMed ID: 28042086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Micellar Formulation of Quercetin Prevents Cisplatin Nephrotoxicity.
    Casanova AG; Prieto M; Colino CI; Gutiérrez-Millán C; Ruszkowska-Ciastek B; de Paz E; Martín Á; Morales AI; López-Hernández FJ
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of quercetin vs cisplatin on proliferation and the apoptotic process in A549 and SW1271 cell lines in in vitro conditions.
    Borska S; Gebarowska E; Wysocka T; Drag-Zalesińska M; Zabel M
    Folia Morphol (Warsz); 2004 Feb; 63(1):103-5. PubMed ID: 15039912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of the Flavonoid Quercetin to Prevent and Treat Cancer - Current Status of Research.
    Jana N; Břetislav G; Pavel S; Pavla U
    Klin Onkol; 2018; 31(3):184-190. PubMed ID: 30441971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced therapeutic efficacy and amelioration of cisplatin-induced nephrotoxicity by quercetin in 1,2-dimethyl hydrazine-induced colon cancer in rats.
    Li QC; Liang Y; Hu GR; Tian Y
    Indian J Pharmacol; 2016; 48(2):168-71. PubMed ID: 27127319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer.
    Li N; Sun C; Zhou B; Xing H; Ma D; Chen G; Weng D
    PLoS One; 2014; 9(7):e100314. PubMed ID: 24999622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of quercetin against cisplatin-induced hair cell damage in zebrafish embryos.
    Lee SK; Oh KH; Chung AY; Park HC; Lee SH; Kwon SY; Choi J
    Hum Exp Toxicol; 2015 Nov; 34(11):1043-52. PubMed ID: 25591968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells.
    Jakubowicz-Gil J; Paduch R; Piersiak T; Głowniak K; Gawron A; Kandefer-Szerszeń M
    Biochem Pharmacol; 2005 May; 69(9):1343-50. PubMed ID: 15826605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy.
    Benkafadar N; Menardo J; Bourien J; Nouvian R; François F; Decaudin D; Maiorano D; Puel JL; Wang J
    EMBO Mol Med; 2017 Jan; 9(1):7-26. PubMed ID: 27794029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells.
    Xu W; Xie S; Chen X; Pan S; Qian H; Zhu X
    Drug Des Devel Ther; 2021; 15():577-588. PubMed ID: 33623367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects.
    Tang SM; Deng XT; Zhou J; Li QP; Ge XX; Miao L
    Biomed Pharmacother; 2020 Jan; 121():109604. PubMed ID: 31733570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of quercetin on cisplatin-induced toxicity in kidney and tumor tissues.
    Sánchez-González PD; López-Hernández FJ; Dueñas M; Prieto M; Sánchez-López E; Thomale J; Ruiz-Ortega M; López-Novoa JM; Morales AI
    Food Chem Toxicol; 2017 Sep; 107(Pt A):226-236. PubMed ID: 28669851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity: Evidence in Patients Receiving Cisplatin Therapy.
    Duffy EA; Fitzgerald W; Boyle K; Rohatgi R
    Clin J Oncol Nurs; 2018 Apr; 22(2):175-183. PubMed ID: 29547601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity.
    Karasawa T; Steyger PS
    Toxicol Lett; 2015 Sep; 237(3):219-27. PubMed ID: 26101797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols.
    Fetoni AR; Paciello F; Troiani D
    Antioxid Redox Signal; 2022 Jun; 36(16-18):1229-1245. PubMed ID: 34731023
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploration of platinum-based dose-intensive chemotherapy strategies with amifostine (Ethyol).
    Schuchter LM
    Eur J Cancer; 1996; 32A Suppl 4():S40-2. PubMed ID: 8976821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Toxicological Research of the Anticancer Drug Cisplatin.
    Qi L; Luo Q; Zhang Y; Jia F; Zhao Y; Wang F
    Chem Res Toxicol; 2019 Aug; 32(8):1469-1486. PubMed ID: 31353895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.